AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

US vs FL-Guided Lumbar Nerve Root Injections

RecruitingNAAges 18 Years - 75 YearsAllTanta University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to learn if ultrasound-guided nerve root injections work as well as fluoroscopy (X-ray)-guided injections to treat lower back and leg pain caused by irritated nerves (lumbosacral radiculopathy) in adults aged 18 to 75 years old. The main questions it aims to answer are: * Does ultrasound guidance lower pain as effectively as fluoroscopy guidance after 3 months? * Does one method help participants recover their ability to do daily activities better than the other? * Are ultrasound-guided injections as fast and safe for participants as fluoroscopy-guided injections? Researchers will compare ultrasound-guided nerve root injections to fluoroscopy-guided nerve root injections to see if ultrasound works to treat the pain just as well while allowing participants to avoid radiation exposure. Participants will: * Receive one targeted nerve injection of medic

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Adults aged 18 to 75 years. * Clinical diagnosis of lumbar radiculopathy characterized by radicular pain, paresthesia, or weakness in a dermatomal distribution. * Magnetic Resonance Imaging (MRI)-confirmed nerve root compression due to disc herniation or foraminal stenosis. * Failure to respond to at least 3 months of conservative medical treatment. * Radiculopathy affecting the L4, L5, or combined L5-S1 levels (where the primary symptomatic level can be reliably targeted) Exclusion Criteria: * Isolated S1 radiculopathy. * Significant spinal deformities, including scoliosis \>20ยฐ or spondylolisthesis \>Grade II. * History of prior lumbar spine surgery. * Bleeding disorders (International Normalized Ratio \[INR\] \>2.5). * Severe uncontrolled diabetes mellitus (HbA1c \>8%). * Advanced cardiac, renal, or hepatic disease. * Active systemic infection or localized infection at the injection site. * Known allergies to corticosteroids or local anesthetics. * Presence of progressive neurological deficits or cauda equina syndrome. * Peripheral neuropathies mimicking radiculopathy. * Pregnancy or breastfeeding. * Severe psychiatric illness or cognitive impairment affecting study compliance.
๐Ÿ’Š

What it tests

  • Ultrasound-Guided Selective Lumbar Nerve Root Injection
  • Fluoroscopy-Guided Selective Lumbar Nerve Root Injection
๐Ÿ“

Where

1 site
Faculty of Medicine, Tanta University.
Tanta, Egypt
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy